Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
NCT06298019
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Dermatomyositis
Interventions
BIOLOGICAL:
KYV-101
Sponsor
Stanford University